LONA Q4 2024 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena

LONALeonaBio, Inc.

$26M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$16M

Net Income

-$15M

EPS (Diluted)

$-3.90

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$59M

Total Liabilities

$14M

Stockholders' Equity

$45M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$16M	-$29M	+46.4%
Net Income	-$15M	-$27M	+45.0%